Javan Esfandiari - Mar 11, 2022 Form 4 Insider Report for CHEMBIO DIAGNOSTICS, INC. (CEMI)

Role: Executive Vice President, Chief Science and Technology Officer
Signature: /s/ Mark L. Johnson, Attorney-in-Fact for Javan Esfandiari
Stock symbol: CEMI
Transactions as of: Mar 11, 2022
Transactions value $: $0
Form type: 4
Date filed: 3/15/2022, 09:30 PM
Previous filing: May 1, 2023
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CEMI	Restricted Stock Units	Award	$0	+144K		$0.00	144K	Mar 11, 2021	Common Stock	144K		Direct	F1, F2
transaction	CEMI	Incentive Stock Options	Award	$0	+69.4K		$0.00	69.4K	Mar 11, 2021	Common Stock	69.4K	$1.25	Direct	F3
transaction	CEMI	Nonqualified Stock Options	Award	$0	+208K	+10413950%	$0.00	208K	Mar 11, 2021	Common Stock	208K	$1.25	Direct	F4

Showing 1 to 3 of 3 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents a contingent right to receive one share of common stock.
F2	On March 16, 2020, the reporting person was granted 144,000 restricted stock units scheduled to vest in equal installments on March 11 of each of 2023, 2024 and 2025, subject to continued service through each vesting date.
F3	The incentive stock options are scheduled to vest and become exercisable over four years, with two shares vesting on March 11, 2023, two shares vesting on March 11, 2024, two shares vesting on March 11, 2025 and the remaining 69,429 shares vesting on March 11, 2026, subject to continued service through each vesting date.
F4	The nonqualified stock options are scheduled to vest and become exercisable over three years, with 69,426 shares vesting on March 11, 2023, 69,427 shares vesting on March 11, 2024, and 69,426 shares vesting on March 11, 2025, subject to continued service through each vesting date.

Remarks:

Executive Vice President, Chief Science and Technology Officer